ROUND TABLE ON HEALTH TECHNOLOGY ASSESSMENT AS A TOOL TO ATTRACT PRIVATE INVESTMENTS FOR FVG BIOHIGHTECH AND AI INNOVATION

/sites/default/files/2025-09/mauri8449_a_hand_of_a_doctor_with_glove_touching_a_virtual_co_0675fc00-2c39-41f4-a7e5-91e65df6809f_2_0.png
Guarda
10:40 - 11:40

ROUND TABLE ON HEALTH TECHNOLOGY ASSESSMENT AS A TOOL TO ATTRACT PRIVATE INVESTMENTS FOR FVG BIOHIGHTECH AND AI INNOVATION

Chair

10:40 am

Dott.ssa Roberta Terpin

Investment Manager Friulia S.p.A 

Co-Chair

10:50

Dott.ssa Elisabetta Borello

Co-Founder - Bio4Dreams S.p.A. - Milano

Speakers

11:00 am

Dott. Gabriele Bellon 

Director - Banca di Credito Cooperativo Venezia Giulia - Trieste

11:10 am

Dott. Antonio Boccia

Head of Equity Capital Markets CFO SIM – Milano

11:20 am

Dott. Antonio Salera (TBC)

Senior Research Analyst - Generali Asset Management

11:30 am

Ing. Floriana Vitale

Director Advisory & Capital Markets / Equity Partner, Irtop Consulting

11:40 am

Ing. Diego Bravar

CEO of Biovalley Partners S.p.A.

12:00 am ONE-TO-ONE MEETINGS AND LIGHT LUNCH